Literature DB >> 1724453

Relationship between naturally occurring human antibodies to casein and autologous antiidiotypic antibodies: implications for the network theory.

C Cunningham-Rundles1, Z K Feng, Z Zhou, K R Woods.   

Abstract

Previous studies on human autologous antiidiotypes have been based largely upon analyses of autoimmune disease. We have previously described polyclonal, naturally occurring human autoantibodies directed against antibodies with specificity toward bovine casein in the sera of IgA-deficient humans. In order to define this system more exactly we have not produced two murine monoclonal antibodies directed against bovine milk kappa-casein to use as clonal tools to identify specific antiidiotypes in these human sera. Kappa-casein is an important part of the casein micelle in milk and cheese; in addition to being an important immunogen for man, kappa-casein is known to have conserved amino acid sequence and two antigenic epitopes. Data presented here show that the serum of up to 74% of IgA-deficient and 10% of normal humans have specific autologous antiidiotypes in their serum which bind to monoclonal antibodies directed to bovine kappa-casein. These human antibodies [intact or F(ab)'2] can be blocked from binding to the monoclonal anti-kappa-caseins by pure bovine kappa-casein or the kappa-casein peptide fragment. In contrast to previous studies in autoimmune disease, serum levels of the autoantiidiotypes were directly proportional to the level of IgG antibody to bovine kappa-casein. These observations suggest that continual exposure to a ubiquitous dietary antigen may produce an antigen driven system in which stimulation of both Ab1 and Ab2 occurs in concert.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724453     DOI: 10.1007/bf00918186

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  39 in total

1.  Analysis by fast protein liquid chromatography of variants of kappa-casein and their relevance to micellar structure and renneting.

Authors:  D G Dalgleish
Journal:  J Dairy Res       Date:  1986-02       Impact factor: 1.904

2.  Production of a monoclonal antibody to bovine kappa-casein.

Authors:  Z K Feng; C Cunningham-Rundles
Journal:  Hybridoma       Date:  1989-04

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis.

Authors:  A K Lefvert
Journal:  Monogr Allergy       Date:  1987

Review 5.  Genetics, expression, and function of idiotypes.

Authors:  K Rajewsky; T Takemori
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

6.  Beneficial autoimmunity?

Authors:  C Janeway
Journal:  Nature       Date:  1982-09-30       Impact factor: 49.962

7.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

8.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

9.  Anti-thyroglobulin anti-idiotypic antibodies in sera of patients with Hashimoto's thyroiditis and Graves' disease.

Authors:  H M Sikorska
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

10.  Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.

Authors:  D S Dwyer; R J Bradley; C K Urquhart; J F Kearney
Journal:  Nature       Date:  1983 Feb 17-23       Impact factor: 49.962

View more
  2 in total

1.  Maintenance of antigen-specific immunological memory through variable regions of heavy and light chains of anti-idiotypic antibody.

Authors:  J Vani; R Nayak; M S Shaila
Journal:  Immunology       Date:  2007-01-11       Impact factor: 7.397

2.  Human immunodeficiency virus (HIV) Tat-reactive antibodies present in normal HIV-negative sera and depleted in HIV-positive sera. Identification of the epitope.

Authors:  T C Rodman; F H Pruslin; S E To; R Winston
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.